Ignite Creation Date:
2024-07-17 @ 10:49 AM
Last Modification Date:
2024-10-26 @ 3:34 PM
Study NCT ID:
NCT06492291
Status:
RECRUITING
Last Update Posted:
2024-07-09
First Post:
2024-07-01
Brief Title:
Open-label Extension Study of Enlicitide Decanoate MK-0616Enlicitide Oral PCSK9 Inhibitor in Adults With Hypercholesterolemia MK-0616-019 CORALreef Extension
Sponsor:
Merck Sharp Dohme LLC
Organization:
Merck Sharp Dohme LLC
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-08-06
Start Date Type:
ESTIMATED
Primary Completion Date:
2028-10-13
Primary Completion Date Type:
ESTIMATED
Completion Date:
2028-10-13
Completion Date Type:
ESTIMATED
First Submit Date:
2024-07-01
First Submit QC Date:
None
Study First Post Date:
2024-07-09
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-10-18
Last Update Post Date:
2024-07-09
Last Update Post Date Type:
ACTUAL